Literature DB >> 1414155

Rare inherited bleeding disorders secondary to coagulation factors in Jordan: a nine-year study.

A S Awidi1.   

Abstract

This work reports on rare inherited coagulation factors defects which were seen in a developing country over a 9-year period. There were a total of 30 cases which fulfilled this diagnosis. Fibrinogen abnormalities were the most frequently encountered. There were 10 patients with afibrinogenemia, 2 with hypofibrinogenemia and 1 case with dysfibrinogenemia. Factor XI deficiency was found in 7 patients, factor V and VII deficiencies accounted for 3 cases each. Factor X and XIII deficiencies were found in 2 patients each. All these rare deficiencies accounted for 10% of all inherited bleeding disorders in the population studied over 9 years.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414155     DOI: 10.1159/000204587

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  2 in total

1.  A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia.

Authors:  N Rosenberg; H Hauschner; H Peretz; R Mor-Cohen; M Landau; B Shenkman; G Kenet; B S Coller; A A Awidi; U Seligsohn
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

2.  αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.

Authors:  Lorena Buitrago; Augusto Rendon; Yupu Liang; Ilenia Simeoni; Ana Negri; Marta Filizola; Willem H Ouwehand; Barry S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.